{"title":"反义技术在泌尿系统肿瘤中的应用。","authors":"Y. Tomita","doi":"10.1089/10915360050138594","DOIUrl":null,"url":null,"abstract":"Antisense oligodeoxynucleotides (ODNs) inhibit target gene expression and are applicable to human diseases including malignancies. Although improvements in ODNs and cellular delivery systems are needed, antisense ODNs hold great promise as a new class of therapeutic agents.","PeriodicalId":80296,"journal":{"name":"Molecular urology","volume":"4 2 1","pages":"55-9"},"PeriodicalIF":0.0000,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/10915360050138594","citationCount":"0","resultStr":"{\"title\":\"Application of antisense technology to urologic cancers.\",\"authors\":\"Y. Tomita\",\"doi\":\"10.1089/10915360050138594\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Antisense oligodeoxynucleotides (ODNs) inhibit target gene expression and are applicable to human diseases including malignancies. Although improvements in ODNs and cellular delivery systems are needed, antisense ODNs hold great promise as a new class of therapeutic agents.\",\"PeriodicalId\":80296,\"journal\":{\"name\":\"Molecular urology\",\"volume\":\"4 2 1\",\"pages\":\"55-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2000-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1089/10915360050138594\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular urology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1089/10915360050138594\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/10915360050138594","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Application of antisense technology to urologic cancers.
Antisense oligodeoxynucleotides (ODNs) inhibit target gene expression and are applicable to human diseases including malignancies. Although improvements in ODNs and cellular delivery systems are needed, antisense ODNs hold great promise as a new class of therapeutic agents.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
